Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,299 total articles
Oklo Inc. Co-Founder and CEO Jacob DeWitte sold 192,462 shares of Class A common stock on February 2, 2026, under a Rule 10b5-1 trading plan adopted March 31, 2025, generating approximately $1.49 million in proceeds. The company also reported a major commercial agreement with Meta to develop a phased 1.2 GW advanced nuclear campus and has seen mult…
Rush Street Interactive COO Mattias Stetz sold 20,000 Class A shares on February 2, 2026, for $353,386 under a pre-arranged 10b5-1 plan. The online gaming operator, valued at about $4 billion, trades below InvestingPro's Fair Value even as its stock is up nearly 17% over the past year. Analysts' price targets range from $20 to $29; Benchmark reaffi…
Dean A. Foate, chairman of Plexus Corp, sold 5,000 shares on February 2, 2026, at $204.8935 for a total of $1024467, lowering his indirect holdings to 15,000 shares held in trust. The next day, 1,370 shares were recorded as acquired through the vesting and settlement of Restricted Stock Units. Separately, Plexus reported first-quarter fiscal 2026 r…
A director of Great Southern Bancorp executed a share sale and option exercises on February 4, 2026, while the company reported Q4 2025 results that topped forecasts and an analyst firm nudged up its price target. Valuation metrics remain low and the company continues a long streak of dividend payments.
Allogene Therapeutics SVP and Chief Technical Officer Benjamin Machinas Beneski sold 7,549 shares on February 2, 2026, for roughly $13,059 to meet tax-withholding obligations tied to vested restricted stock units. The same day he recorded large option and restricted stock unit grants. The company is characterized by recent analyst coverage, clinica…
TTM Technologies director Thomas T. Edman disposed of 16,800 shares on February 2, 2026, through a 10b5-1 plan, generating proceeds of roughly $1.6 million at $96.12 per share. Since the sale the stock has risen to $107.57, trading close to its 52-week high of $111. The company has reported substantial returns over recent periods and secured a mult…
Stryker Group President James Andrew Pierce reported multiple stock transactions on February 2, 2026, including the sale of 475 shares and the exercise of options for 13,840 shares. The moves were disclosed in a Form 4 filing that also shows additional disposals and current direct and indirect holdings. Separately, Stryker reported fourth-quarter 2…
Jabil SVP and Chief Human Resources Officer Gary K. Schick reported the sale of 422 shares on February 2, 2026, executed under a Rule 10b5-1 plan adopted January 31, 2025, totaling $102,871. The company also priced $1 billion in senior notes, declared a quarterly dividend, made a minority investment in Eagle Harbor Technologies, and updated its boa…
AAR Corp's chairman, president and CEO John McClain Holmes III sold 10,000 shares on February 3, 2026, realizing $1,084,363 at a weighted average price of $108.4363, while also exercising options and donating shares to charity. The moves come as the stock trades near a 52-week high and follows a fiscal quarter that topped analyst estimates, prompti…
Wintrust Financial Corp Vice Chair Lee David Eric sold 558 shares on January 30, 2026, for $147.42 each, totaling $82,260 and leaving him with 16,085 shares. Since the sale, WTFC has traded up to $156.04, close to its 52-week peak of $156.16. The bank announced a 10% quarterly dividend increase to $0.55 per share and has attracted elevated analyst …
Levi Strauss & Co. SVP and General Counsel David Jedrzejek sold 2,248 shares of Class A common stock on February 3, 2026, for $44,060, after receiving restricted stock units and stock appreciation rights on January 30, 2026. The company reported Q4 2025 results that beat consensus on both EPS and revenue, yet the stock fell in after-hours and subse…
Reddit CEO Steve Huffman sold 17,997 Class A shares on January 30, 2026, in transactions tied to option exercises that generated roughly $3.3 million. The stock has since fallen to $165.41, a 14.36% decline over the past week. The trades were executed through The XYZ Revocable Trust under a Rule 10b5-1 plan adopted in May 2025. Huffman still holds …
Chevron Chief Financial Officer Eimear P. Bonner carried out a sequence of stock transactions at the end of January 2026, selling 32,100 shares for roughly $5.6 million while simultaneously acquiring the same number of shares via option exercise. The moves were made under a pre-established trading plan and were followed by additional disposals and …
Fortinet President and CEO Xie Ken sold 175,637 shares on Feb. 2, 2026, realizing roughly $14.3 million, while also exercising stock options on Feb. 1 and Feb. 2 and disposing shares to cover RSU-related taxes. The moves come as the company prepares to report quarterly results and as brokerages and market checks deliver a range of views on demand a…
Peter Radovich, president and COO of Mirum Pharmaceuticals (MIRM), sold 2,631 shares on February 2, 2026, to satisfy tax withholding tied to vesting restricted stock units. The transaction left him with a direct ownership of 20,655 shares. Separately, Mirum reported preliminary unaudited net product sales for 2025 of about $520 million, provided 20…
Mirum Pharmaceuticals CEO Christopher Peetz sold 9,108 shares on February 2, 2026, for $940,888 to cover tax withholding tied to restricted stock unit vesting. The company, valued at $6.3 billion and trading close to its 52-week high, reported robust preliminary 2025 product sales and has revised expectations for 2026 growth while completing a stra…
Jolanda Howe, senior vice president and global controller at Mirum Pharmaceuticals, sold 968 shares of common stock on February 2, 2026, in a transaction recorded to satisfy tax withholding tied to restricted stock unit vesting. The company reported preliminary unaudited net product sales of about $520 million for 2025, issued guidance of $630 mill…
Joseph H. Griffith IV, chief financial officer of 908 Devices Inc., sold 23,175 shares on February 2, 2026, generating about $143,221 in proceeds. The sale occurred as the stock traded near $6.44, following a strong 171.73% gain for the prior 12 months. One day earlier, Griffith received 70,035 shares upon settlement of restricted stock units. Prel…
Kevin J. Knopp, President and CEO of 908 Devices Inc (NASDAQ:MASS), sold 34,764 shares of common stock on February 2, 2026, generating about $214,841 at a weighted average price between $6.105 and $6.32. The sale followed the exercise of 108,999 restricted stock units on February 1, 2026. Separately, the company reported preliminary unaudited full-…
Pinterest Chief Content Officer Ducard Malik sold 2,293 shares of Class A common stock on February 2, 2026, for $22.06 per share, a transaction totaling $50,583. The sale took place while Pinterest shares were trading close to a 52-week low and ahead of the company's February 12 earnings release. The company has reported expected fourth-quarter rev…
A group of TCG Crossover entities bought $202,534 worth of Surrozen, Inc. (NASDAQ: SRZN) common shares across transactions executed Jan. 30 - Feb. 3, 2026, at prices ranging from $21.38 to $21.94. Separately, Surrozen announced the immediate resignation of board member Shao-Lee Lin, M.D., Ph.D., with the company stating the departure was not due to…
Stephen Cavoli, Executive Vice President at Virtu Financial, recorded multiple transactions in late January and early February 2026, including sales of Class A common stock and the conversion of restricted stock units into shares. The filings disclose a total of 38,285 shares sold across two reports and 47,809 shares acquired through RSU conversion…
Lauren Riker, Senior Vice President of Finance at Pacira BioSciences, sold 4,000 shares on Feb. 2, 2026, for roughly $83,240 at a weighted average price of $20.81. She also sold 2,751 shares on Jan. 30, 2026, to cover tax withholding tied to restricted stock unit vesting. After these moves Riker directly owns 52,313.242 shares. The transactions com…
Kristen Williams, Chief Administrative Officer at Pacira BioSciences, sold shares in two transactions late January and early February 2026 under a Rule 10b5-1 plan. The company reported record 2025 revenue driven by EXPAREL sales, announced an exclusive distribution agreement with LG Chem for select Asia-Pacific markets, expanded its board and disc…
Kemper J Mariner, UMB Financial Corp's chairman and chief executive officer, sold 18,714 shares of the bank's common stock on February 2, 2026, for approximately $2.4 million. The disposals came while the company traded close to its 52-week high and following a fourth-quarter 2025 performance that outpaced analyst expectations on both earnings and …
